UPC

Universe Pharmaceuticals Inc. (UPC) ESG Analysis Analysis (2026)

Invetso Score: 5.9/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.8 (Moderate)

R&D intensity of 3.7% of revenue suggests some product-efficiency investment, but peer-relative environmental advantage remains unclear without disclosed emissions or energy data.

Low debt-to-equity of 0.17 can support capital flexibility for environmental compliance, yet peers with explicit decarbonization metrics still appear better positioned.

No stock-based compensation burden reduces incentive-driven pressure on near-term cost cutting, but it does not materially evidence stronger environmental stewardship versus peers.

High net debt to EBITDA of 13.8 may constrain funding for environmental upgrades, leaving UPC less flexible than peers with stronger balance-sheet capacity.

Social

Score:

Zero stock-based compensation to revenue indicates limited dilution pressure, but it provides little direct evidence of stronger employee alignment or retention versus peers.

Gross margin of 35.9% can support workforce investment and service continuity, although peers with disclosed safety, training, and engagement metrics remain more transparent.

Moderate R&D spending may help product quality and customer outcomes, but the absence of disclosed labor, diversity, or community metrics limits relative social strength.

High leverage can increase operational pressure on stakeholders during downturns, making UPC less resilient than peers with stronger balance-sheet buffers.

Governance

Score:

Zero stock-based compensation is a positive governance signal because it reduces dilution and incentive complexity relative to peers that rely heavily on equity pay.

Debt-to-equity of 0.17 indicates conservative capital structure governance, although peers with lower leverage and clearer liquidity profiles still look stronger.

R&D at 3.7% of revenue suggests some board support for long-term investment discipline, but governance disclosure remains limited versus better-reporting peers.

Net debt to EBITDA of 13.8 is a material governance concern because it raises refinancing and covenant risk relative to peers with cleaner balance sheets.

Overall Score

Score:

UPC screens as a moderate ESG peer because limited positive governance signals are offset by weak disclosure and materially higher leverage than stronger peers.

Score Driver: High Net Debt To EBITDA Materially Weakens Relative ESG Positioning Across Environmental, Social, And Governance Dimensions.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Universe Pharmaceuticals Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →